Patient Testimonies | June 22, 2025
Hi there! My name is Susan Vigen, and I am from South Carolina. I am a patient who has struggled and lived with a severe overactive bladder and interstitial cystitis, requiring me to take the medication Myrbetriq.
This medication, produced by Astellas Pharma, has a list price of $460.30 and is charged to my insurance at $1677 for a 90 day supply, and a monthly copay responsibility for me that increased from $120 to $365 every 90 days starting last fall. This is simply too expensive for me and while there is a generic version of the drug called Mirabegron, my insurance will not cover it. Thus, I am left constantly looking for cheaper pharmacies and ways to save.
Overall, Myrbetriq is too expensive and my battles in getting something cheaper have caused me undue emotional distress. I worry about the cost every time I need to request a refill, along with the additional increasing costs of my other prescriptions.
And as someone who used to work in the pharmaceutical industry for about 17 years on the data management side, I understand the cost of bringing a drug to market and the need for some profit making to be made, however, I am now the patient feeling the financial frustration. – Patients need lower prices now.